Christopher Ryan Sullivan - Jun 9, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Chief Financial Officer
Signature
/s/ Jennifer Zoltoski, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Jun 9, 2023
Transactions value $
$1,748
Form type
4
Date filed
6/13/2023, 04:41 PM
Previous filing
May 17, 2023
Next filing
Aug 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $1.75K +511 +68.04% $3.42* 1.26K Jun 9, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.